nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty
|
Bittl, John A. |
|
1995 |
130 |
3P2 |
p. 658-665 8 p. |
artikel |
2 |
Conventional antithrombotic approaches
|
Ferguson III, James J. |
|
1995 |
130 |
3P2 |
p. 651-657 7 p. |
artikel |
3 |
Coronary lesions at increased risk
|
Ellis, Stephen G. |
|
1995 |
130 |
3P2 |
p. 643-646 4 p. |
artikel |
4 |
Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents
|
Tcheng, James E. |
|
1995 |
130 |
3P2 |
p. 673-679 7 p. |
artikel |
5 |
Identification of intervention patients at increased risk
|
Bertrand, Michel E. |
|
1995 |
130 |
3P2 |
p. 647-650 4 p. |
artikel |
6 |
Introduction
|
Topol, Eric J. |
|
1995 |
130 |
3P2 |
p. 641-642 2 p. |
artikel |
7 |
Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb IIIa inhibitors
|
Topol, Eric J. |
|
1995 |
130 |
3P2 |
p. 666-672 7 p. |
artikel |
8 |
Restenosis: The cost to society
|
Califf, Robert M. |
|
1995 |
130 |
3P2 |
p. 680-684 5 p. |
artikel |